Enzalutamide monotherapy in patients with hormone-naïve prostate cancer: 1.year extended follow-up of a phase 2 study.

Michael Borre, Matthew Smith, Per Rathenborg, Patrick Werbrouck, Hendrik van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, D. Phung, Benoit Baron, Mohammad Hirmand, Bertrand Tombal

Original languageEnglish
Article numberP060
JournalEuropean Urology Supplements
Issue number131
Pages (from-to)131
Publication statusPublished - 2014

Cite this